Substantiation of the model of pricing for essential drugs in the context of the Health Technology Assessments
DOI:
https://doi.org/10.24959/nphj.17.2139Keywords:
pricing, essential drugs, National list of drugs, Health Technology AssessmentsAbstract
The problem of availability of drugs can be solved by implementation of effective social and economic mechanisms.
Aim. To substantiate theoretically the effective management model of pricing for drugs.
Materials and methods. The analysis of drug availability has been conducted; the model of pharmaceutical pricing has been proposed.
Results and discussion. The effective social pricing model for drugs has been proposed. This model is based on the use of a consolidated list of essential drugs, the method of forming the cost of drugs, scientifically based methods of the state regulation of prices and the results of the Health Technology Assessments .
Conclusions. Implementation of effective social pricing model allows improving drug availability and pharmaceutical care for the population.
References
Intersectoral Governance for Health in All Policies Structures, actions and experiences [Електронний ресурс] / D. V. McQueen, M. Wismar, L. Vivian et al. // WHO, European Observatory on Health Systems and Policies. – 2012. – Режим доступу : http://www.euro.who.int/__data/assets/pdf_file/0005/171707/Intersectoral–governance–for–health–in–all–policies.pdf.
Немченко, А. С. Ціноутворення на лікарські засоби / А. С. Немченко, К. Л. Косяченко, О. А. Немченко. – Х. : Авіста–ВЛТ, 2012. – 304 с.
Немченко, А. С. Обґрунтування пріоритетних напрямків удосконалення ціноутворення на лікарські засоби / А. С. Немченко, В. М. Назаркіна // Укр. вісник психоневрол. – 2015. – № 3. – С. 118–122.
Danzon, P. M. Pharmaceutical Price Regulation: National Policies Versus Global Interests [Електронний ресурс] / P. M. Danzon // The AEI Press. – 2010. – Режим доступу : https://www.aei.org/wp–content/uploads/2014/07/–pharmaceutical–price–regulation–global–interests_11361924090.pdf.
Carone, G. European Economy. Cost–containment policies in public pharmaceutical spending in the EU [Електронний ресурс] / G. Carone, C. Schwierz, A. Xavier // European Commission. Economic Papers 461. – 2012. – Режим доступу : http://ec.europa.eu/economy_finance/publications/economic_paper/2012/pdf/ecp_461_en.pdf
Essential Medicines Are More Available than Other Medicines around the Globe [Електронний ресурс] / Y. T. Bazargani, M. Ewen, A. de Boer et al. // PLOS. – 2014. – Режим доступу : http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087576
Ruggeri, K. Pharmaceutical pricing. The use of external reference pricing / K. Ruggeri, E. Nolte. –Cambridge, 2013. – 61 p.
Pinson, N. Health Technology Assessment / N. Pinson, A. Thielke, V. King. –Portland, 2011. – 146 p.
Исследования сравнительной эффективности / Д. Ю. Белоусов, А. С. Колбин, А. А. Курылев, А. В. Павлыш // Качественная клин. практика. – 2013. – № 1. – С. 70–77.
Kosyachenko, K. L. Methodological approaches to development of the national guidelines of the health technology assessment / K. L. Kosyachenko, A. S. Nemchenko // Вісник фармації. – 2014. – № 1. – С. 54–57.
Оценка медицинских технологий и формирование политики здравоохранения в странах Европы: Современное состояние, проблемы и перспективы [Електронний ресурс] // ВОЗ, Европейская Обсерватория по системам и политике здравоохранения. – 2010. – Режим доступу : http://www.euro.who.int/__data/assets/pdf_file/0005/128525/e91922R.pdf.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
